MedTrace Logo

Efficacy of Platelet Rich Plasma Injection in Diabetic Neuropathy

NCT03250403 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-07-13

No results posted yet for this study

Summary

To evaluate the clinical efficacy and safety of peri-neural platelet rich plasma (PRP) injection in the treatment of diabetic peripheral neuropathy compared to traditional medical treatment.

Conditions

  • Diabetic Peripheral Neuropathy

Interventions

DRUG

PRP injection

peri-neural injection of platelet rich plasma

OTHER

traditional medical treatment

traditional medical treatment

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Abdelraheem M Alawaamy, Dr · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2017-08-01
Completion
2017-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03250403 on ClinicalTrials.gov